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Summary Background The diagnosis of mycosis fungoides (MF) is notoriously difficult to establish because in
the early stages, histological features may be nonspecific or merely suggestive.
Objectives To standardize the diagnosis of MF.
Methods We studied 138 patients with suspected MF referred over a 7-year period to a university
department of a dermatology-based cutaneous lymphoma clinic. Six diagnostic criteria were
evaluated: clinical morphology, clinical distribution, skin biopsy T-cell receptor gene rearrangement
(TCR-GR), skin biopsy pan T-cell marker loss ‡ 2, skin biopsy CD4 ⁄ CD8 ratio ‡ 6, and skin biopsy
diffuse epidermal HLA-DR expression. These six clinical and laboratory criteria were compared by
logistic regression analysis in patients with histologically diagnosed MF and those with benign disease.
Results Of the 138 patients, 74 had histology of MF, 47 of benign dermatoses and 17 were
indeterminate. Close associations were found between a histological diagnosis of MF and TCR-GR
(odds ratio 14Æ4), classical morphology (7Æ5), classical distribution (2Æ5) and diffuse epidermal HLA-DR
expression (2Æ8). Logistic regression models were developed depending on the availability of data
(either TCR-GR or HLA-DR). Probabilities for correctly diagnosing MF compared with histology as the
gold standard were derived from these logistic regression models. A scoring system assigning point
values based on these probabilities was then created in order to assist the clinician in making the
diagnosis. If using TCR-GR data, a positive TCR-GR ¼ 2Æ5 points, the presence of classical
morphology ¼ 2Æ0 points, and the presence of classical distribution ¼ 1Æ5 points. A total score of
‡ 3Æ5 points assigns a high probability (> 85%) of having MF. If using HLA-DR expression, then the
presence of classical morphology ¼ 2Æ5 points, a positive diffuse epidermal HLA-DR expression ¼ 2Æ0
points, and the presence of classical distribution ¼ 1Æ5 points. In this case, a total score of ‡ 4Æ0 points
assigns a high probability (> 85%) of MF.
Conclusions The logistic regression models and scoring systems integrate clinical and laboratory
assessments, allow rapid probability estimation, and provide a threshold for the diagnosis of MF in an
objective, standardized manner.
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Mycosis fungoides (MF) is typically an indolent lympho-
proliferative disorder of neoplastic T cells which
initially presents in the skin. The lesions can vary
morphologically. Classical lesions often begin as well-
demarcated scaling patches; with time, lesions may
become more indurated, forming plaques and tumours.
Patients’ lesions may also display a characteristic
distribution over doubly clothed areas.
The diagnosis of MF is notoriously difficult to establish
because in the early stages, histological features may be
nonspecific. Although light microscopic findings have
remained the gold standard for diagnosis, most studies
show both inter- and intrarater variability in the early
histological diagnosis to be high, even among highly
experienced dermatopathologists.1–4
To improve the reproducibility and sensitivity of the
diagnosis of MF, key histological features have been
identified5–8 and several adjunctive tests developed
through the years. To define the malignant infiltrate,
various tests have been employed: abnormal nuclear
DNA content and chromosome complement,9–12 abnor-
mal nuclear contour and shape,13–17 loss of pan T-cell
markers,18,19 elevated CD4 ⁄ CD8 ratio (‡ 6),20 diffuse
epidermal HLA-DR expression,21 and the presence of a
clonal T-cell population as measured by T-cell receptor
gene rearrangement (TCR-GR) studies.22–25 None of
these tests alone firmly establishes the diagnosis of MF.
In other complex diseases, such as systemic lupus
erythematosus and atopic dermatitis, important clinical
and laboratory criteria have been identified to make
standardized scoring systems26–28 to aid in making the
diagnosis. We propose a method to standardize the
early diagnosis of MF integrating both clinical features
and adjunctive laboratory tests. Two logistic regression
models were developed based on the statistically
significant associations of certain diagnostic criteria
compared with the gold standard of histological
diagnosis. The models assign a probability that the
diagnosis of MF is correct. From these probabilities, a
scoring system to simplify patient assessment is pro-
posed with relative weights given to each diagnostic
criterion; scores above a defined threshold equate with
a high probability (> 85%) of having MF in cases
where histology is equivocal.
Materials and methods
Patients
Over a 7-year period, 138 patients with documented or
suspected MF who were referred to a Cutaneous
Lymphoma Program received a standardized evalua-
tion. Clinical assessment consisted of documenting the
morphology and distribution of all lesions as either
classical, consistent or atypical for MF. Classical mor-
phology was defined as scaling poikilodermatous pat-
ches with fine epidermal wrinkling (poikiloderma
atrophicans vasculare), leonine facies, well-demarca-
ted, indurated, scaling plaques, or tumours (Fig. 1a–c).
Consistent morphology was defined as scaling derma-
titis, erythroderma or alopecia mucinosa. Atypical
morphology was defined as nonscaling lesions, with
Figure 1. Classical morphology of mycosis fungoides. (a) Scaling patches with epidermal wrinkling; (b) indurated erythematous plaques;
(c) indurated erythematous tumours.
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none of the above specific features. Patients such as in
Figure 1(c) with obvious MF were excluded from
consideration, but patients with tumours that were
legitimately considered to represent possible prurigo
nodules were included. A classical distribution included
involvement primarily of the buttocks, lower trunk,
upper thighs, upper inner arms, and the periaxillary
and inframammary areas (Fig. 2a,b). Consistent distri-
bution was defined as involvement primarily of the
extremities, head or upper trunk in addition to the
classical distribution. Atypical distribution was defined
as distribution not fitting into the above categories.
Skin biopsy specimens were taken from the most
clinically infiltrative and advanced lesions in all
patients and analysed by a staff dermatopathologist.
Histological evaluation
Biopsies were obtained from patients after at least
1 month off any medications except bland emollients.
The major histological criterion used was the degree of
lymphocyte atypia (based on nuclear size, density and
convolution); other criteria included published mor-
phological features and patterns such as epidermotro-
pism, and the presence of a band-like upper dermal
lymphocytic infiltrate in which cells are apposed to
basal cells singly and in a linear arrangement (Fig. 3a–
c).6 The overall degree of certainty of the pathologist
was expressed using the following terms: (i) not MF; (ii)
suggestive of MF; (iii) consistent with MF; and (iv)
diagnostic of MF. Patients were classified as having
benign disease if repeated biopsies showed no evidence
of MF or if features were only suggestive of MF, and as
having MF if histological features were consistent with
or diagnostic of MF.
Immunophenotyping
Immunophenotyping by immunohistochemical stain-
ing of frozen skin biopsy specimens was carried out
using an avidin–biotin–peroxidase technique.29 Sec-
tions were stained with a panel of monoclonal anti-
bodies (Becton-Dickinson, San Jose, CA, U.S.A.),
including anti-HLA-DR, CD2 (Leu 5b), CD3 (Leu 4),
CD4 (Leu 3a), CD5 (Leu 1), CD7 (Leu 9) and CD8 (Leu
2a). We recorded the CD4 ⁄ CD8 ratio, number of pan
T-cell markers lost (CD2, CD3, CD5, CD7) and presence
of expression of HLA-DR by epidermal keratinocytes, as
stated in the pathologist’s report.
T-cell receptor gene rearrangement
For TCR-GR studies, DNA was extracted from frozen
tissue according to standard protocols.30 Ten micro-
grams of DNA were digested with the restriction
enzymes BamHI, EcoRI and HindIII. Restriction
fragments were size-fractionated by agarose gel elec-
trophoresis. Southern blots were hybridized with 32P-
radiolabelled probes (Oncor, Gaithersburg, MD, U.S.A.)
for the constant region (CT Beta) and ⁄ or for the
joining regions (J Beta 1 ⁄ 11) of the T-cell receptor b
chain gene (TCR-GR). The diagnosis of a monoclonal
rearrangement required that nongermline bands were
seen with two of the three enzymes, or that two
nongermline bands were seen with one single enzyme
digest.31
Figure 2. Classical distribution of mycosis fungoides. (a) Involvement
of posterior axillary fold; (b) involvement of buttocks. Involvement of
upper thighs and upper inner arms is not shown.
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Statistical analysis
Clinical and histological features and adjunctive test
data were entered prospectively into a dBase IV database
(Microsoft, Seattle, WA, U.S.A.). Statistical analysis was
performed using the statistical analysis package STATA
(release 3Æ1, College Station, TX, U.S.A.). In total, six
clinical or adjunctive test features were examined. These
candidate diagnostic criteria included the following:
classical morphology, classical distribution, pan T-cell
marker loss ‡ 2, presence of a TCR-GR, CD4 ⁄ CD8 ratio
‡ 6, and diffuse epidermal HLA-DR expression. The
statistical significance of the association of each diag-
nostic criterion with histology, the gold standard for
diagnosis of MF, was assessed using Fisher’s exact test in
a univariate analysis. These tests were performed on all
patients with available data. Data were missing for some
patients due to the lack of availability of TCR-GR
techniques early in the study period, inadequate DNA
yield from biopsy specimens, and variations in the
assessment by evaluating physicians.
Logistic regression models were used to assess the
independent associations of each diagnostic criterion
with a histological diagnosis of MF. Statistical signifi-
cance was assessed using the Wald test in the multi-
variate analysis. Two situations were explored, one in
which TCR-GR information was used and one in which
it was not. In each situation the most predictive model
for a diagnosis of MF was determined through a step-up
procedure based on maximizing the log likelihood
function. Models were based on cases with complete
data available for all the criteria included in the model.
Diagnostic criteria were entered if they were significant
at the 10% level by the likelihood ratio test. The model-
predicted probability of a diagnosis of MF was calcu-
lated using the formula:
Predicted probability ¼ exp½XB=ð1 þ exp½XBÞ;
where XB is the linear predictor.
Two scoring systems were developed based on the best
models, one in which TCR-GR data were used, and one in
which they were not. Firstly, the model coefficients (log
odds ratio) were standardized by dividing by their
standard errors. Next, the relative weights (points) were
determined based on a maximum score of 6Æ0 by dividing
each standardized coefficient by the sum of the stan-
dardized coefficients in the model and multiplying by 6Æ0.
Results
Statistically significant univariate associations were found
between the histological diagnosis of mycosis fungoides and
positive T-cell receptor gene rearrangement, classical
morphology, classical distribution and diffuse epidermal
HLA-DR expression, but not CD4 ⁄ CD8 ratio ‡ 6 or pan
T-cell marker loss ‡ 2
Of 138 total patients based on histological classification,
47 patients were assigned to the benign dermatoses
group. These included the following diagnoses:
Figure 3. Histology diagnostic of mycosis fungoides. (a) Low-power view showing lymphocytic infiltration of the epidermis (epidermotropism); (b) high-
power view showing band-like lymphocytic infiltration of the dermis; (c) high-power view showing lymphocyte atypia (haematoxylin and eosin).
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spongiotic dermatitis, interface dermatitis, psoriasiform
dermatitis, delayed-type hypersensitivity reaction, be-
nign lymphocytic infiltrate, pityriasis lichenoides et
varioliformis acuta (PLEVA) and pseudolymphoma.
Histological classification assigned 74 patients to the
MF group; 17 were indeterminate. Using the two patient
populations (benign dermatoses and MF + indetermin-
ate), univariate associations between the six clinical and
adjunctive test data (diagnostic criteria) and the histo-
logical diagnosis of MF were determined (Table 1). All
but one patient had morphology and distribution recor-
ded, but other variables were not available for some
patients; thus, the number of observations (n) varies by
parameter. To quantify the strength of association
between each criterion and a histological diagnosis of
MF, an odds ratio was generated. Statistically significant
associations, as expressed by P £ 0Æ1, were found with
positive TCR-GR (odds ratio 14Æ4), classical morphology
(7Æ5), classical distribution (2Æ5) and diffuse epidermal
HLA-DR expression (2Æ8) (Table 1). CD4 ⁄ CD8 ratio ‡ 6
showed a weak association (odds ratio 2Æ2, P ¼ 0Æ12),
but pan T-cell marker loss ‡ 2 appeared to be unrelated
to the histological diagnosis of MF (P > 0Æ999).
Development of logistic regression models for diagnosis
of mycosis fungoides by multivariate analysis
T-cell receptor gene rearrangement data used. A logistic
regression model was built using the diagnostic
criteria in a step-up procedure. Odds ratios were
generated and significant independent associations
expressed as P £ 0Æ1 (Wald test). The most predictive
model incorporates the criteria that have the most
statistically significant associations with a diagnosis of
MF: TCR-GR, morphology and distribution (Table 2).
Although diffuse epidermal HLA-DR expression was a
statistically significant variable based on the univari-
ate analysis, it did not contribute to the overall
diagnostic utility of the final model when TCR-GR
data were available. The sensitivity and specificity of
this model was determined using our two histologi-
cally defined patient groups. A positive predictive
value of 82% with a sensitivity of 85% and a
specificity of 58% was derived (Table 3).
Once created, the most predictive logistic regression
model assigned a probability of having MF to each
patient based on clinical features and TCR-GR data.
The frequency distribution of patients at each prob-
ability level revealed distinct groupings which allowed
patients to be divided crudely into low (P £ 0Æ40),
intermediate (0Æ60 £ P £ 0Æ85) or high (P > 0Æ85) risk
categories (Fig. 4a). In the MF group, 31 of 74 (42%)
patients had a high probability, 32 of 74 (43%) had
an intermediate probability and 11 of 74 (15%) had a
low probability of having MF. In the benign derma-
toses group, two of 33 (6%) patients had a high
probability, 12 of 33 (36%) had an intermediate
probability and 19 of 33 (58%) had a low probability
of having MF. The two patients in the benign
dermatoses group with a high probability of MF had
Table 1. Statistically significant univariate
associations of histological diagnosis of
mycosis fungoides (MF) with T-cell receptor
gene rearrangement (TCR-GR), morphology,







TCR-GR 2 (34) 35 (74) 14Æ36 £ 0Æ0001
Morphology 4 (46) 38 (91) 7Æ5 0Æ0001
Distribution 12 (46) 43 (91) 2Æ54 0Æ026
HLA-DR expression 10 (28) 38 (62) 2Æ85 0Æ039
CD4 ⁄ CD8 ratio 7 (33) 27 (73) 2Æ18 0Æ121
Pan T-cell marker loss 5 (32) 13 (74) 1Æ15 ‡ 0Æ999
aEntries are the number with positive criteria out of (n) with available data. Positivity is defined
as presence of TCR-GR, classical lesional morphology, classical lesional distribution, diffuse
epidermal HLA-DR expression, CD4 ⁄ CD8 ratio ‡ 6 and pan T-cell marker loss ‡ 2. bOdds ratios
express the strength of association between the individual diagnostic criterion and a diagnosis of
MF. cStatistical significance of associations is expressed as P £ 0Æ1 using Fisher’s exact test.
Table 2. Establishment and performance of
logistic regression model for diagnosis of
mycosis fungoides (MF) when T-cell receptor
gene rearrangement (TCR-GR) data are used:
most predictive logistic regression modela
Diagnostic criteriaa Estimated odds ratio Standard error P-valueb
TCR-GR 13Æ10 10Æ38 0Æ001
Morphology 4Æ70 2Æ93 0Æ013
Distribution 2Æ53 1Æ29 0Æ068
aModel is based on 107 patients with complete data for all the criteria used. bStatistical signi-
ficance of associations is expressed as P £ 0Æ1, using the Wald test.
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been classified histologically with a diagnosis of
spongiotic dermatitis and PLEVA, respectively. Unfor-
tunately, these patients have been lost to follow-up, so
it is unclear whether they eventually developed
histologically confirmed MF.
T-cell receptor gene rearrangement data not used. Epi-
dermal HLA-DR expression was a statistically
significant variable when univariate analysis was
performed (Table 1), but in the presence of TCR-GR
data its usefulness in making the diagnosis of MF was
not appreciated. A second logistic regression model was
developed which incorporated clinical and HLA-DR
expression data (Table 4). The sensitivity and specificity
of this model (89% and 46%, respectively, Table 5) were
similar to those obtained for the most predictive model in
which TCR-GR data were utilized. The positive predictive
value of this second model was estimated at 79%.
Based on this second model, patients were divided
into low (P £ 0Æ40), intermediate (0Æ60 £ P £ 0Æ85)
and high (P > 0Æ85) risk categories for having MF
(Fig. 4b). The division between these categories was
based on that established in the first model. In the MF
group, 20 of 62 (32%) patients had a high probability,
35 of 62 (56%) had an intermediate probability and
seven of 62 (11%) had a low probability of having MF.
In the benign dermatoses group, two of 28 (7%)
patients had a high probability, 13 of 28 (46%) had an
intermediate probability and 13 of 28 (46%) had a low
probability of having MF.
Table 3. Establishment and performance of
logistic regression model for diagnosis of
mycosis fungoides (MF) when T-cell receptor
gene rearrangement (TCR-GR) data are used:





Classified by histology Benign dermatoses 19 14 33
MF 11 63 74
Total 30 77 107
Model sensitivity, 85%; model specificity, 58%; false positive rate, 18%; false negative rate, 37%;
positive predictive value, 82%; negative predictive value, 63%. aThe sensitivity and specificity of
the logistic regression model is based on application of the model to the histologically defined
benign dermatoses and MF groups.
Figure 4. Comparison of mycosis fungoides (MF) probability distri-
butions between histologically defined benign dermatoses and MF
type cutaneous T-cell lymphoma (CTCL). Most patients with benign
disease are in the low probability group, while most MF patients are
in the intermediate-high probability group. (a) Based on the logistic
regression model developed from clinical and immunogenotyping
data including T-cell receptor gene rearrangement (TCR-GR) data.
(b) Based on the logistic regression model developed from clinical and
HLA-DR expression data (TCR-GR data not used).
Table 4. Establishment and performance of logistic regression model
for diagnosis of mycosis fungoides (MF) when T-cell receptor gene
rearrangement (TCR-GR) data are not used: logistic regression model
utilizing HLA-DR expression instead of TCR-GR dataa
Diagnostic criteriaa Estimated odds ratio Standard error P-valueb
Morphology 4Æ43 2Æ75 0Æ016
HLA-DR expression 2Æ71 1Æ36 0Æ047
Distribution 2Æ43 1Æ30 0Æ097
aModel is based on 90 patients with complete data for all the criteria
used. bStatistical significance of associations is expressed as P £ 0Æ1,
using the Wald test.
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Practical scoring system to establish a diagnosis
of mycosis fungoides
A clinically useful scoring system was developed from
each of the logistic regression models presented in
Tables 2–5. A numerical value was given to each
criterion based on its strength of association with the
diagnosis of MF based on the relative magnitude of the
estimated log odds ratio (Tables 6 and 7). For both
systems, as a score increased, the corresponding prob-
ability of a diagnosis of MF increased until probabilities
approached 1Æ0 (Fig. 5). In patients with a score of 0,
the probability of having MF was £ 0Æ40. This probab-
ility value was not 0 because a small number of cases
diagnosed histologically as MF were classified as benign
by the model. Therefore, patients with this score had a
finite, but small, chance of having malignant disease.
This was appropriate because these patients were
judged clinically to have disease suspicious for MF.
Scores of 1Æ5–2Æ5 in patients with TCR-GR data avail-
able, and scores of 1Æ5–3Æ5 in patients without TCR-GR
data were associated with an intermediate probability
(0Æ60–0Æ85) of having MF. Scores ‡ 3Æ5 in patients with
TCR-GR data available, and scores ‡ 4Æ0 in patients
without TCR-GR data were associated with a high
probability (> 0Æ85) of having MF.
Discussion
The diagnosis of MF has traditionally been based on the
correlation of clinical and histological features, leading
to inconsistent and often incorrect diagnoses. Numer-
ous studies show low accuracy and reliability of
histological and cytological interpretation of skin
biopsy specimens, which led us to search for an
improved method of diagnosis.1–4 The diagnostic
value of clinical assessment has not previously been
Table 5. Establishment and performance of logistic regression model
for diagnosis of mycosis fungoides (MF) when T-cell receptor gene
rearrangement (TCR-GR) data are not used: logistic regression model
sensitivity and specificitya
Classified by model
Benign dermatoses MF Total
Classified by histology Benign
dermatoses
13 15 28
MF 7 55 62
Total 20 70 90
Model sensitivity, 89%; model specificity, 46%; false positive rate,
21%; false negative rate, 35%; positive predictive value, 79%; neg-
ative predictive value, 65%. aThe sensitivity and specificity of the
logistic regression model is based on application of the model to the
histologically defined benign dermatoses and MF groups.
Table 6. Scoring system to estimate probability of diagnosis of
mycosis fungoides (MF). Steps in patient evaluation: (1) clinical
evaluation (differential diagnosis includes MF; lesional morphology
and distribution are assessed); (2) biopsy (histology is at least sug-
gestive of diagnosis of MF); (3) adjunctive tests [T-cell receptor gene
rearrangement (TCR-GR) studies or epidermal HLA-DR expression];







Positive lesional TCR-GR 2Æ5 –
Classical morphology 2Æ0 2Æ5
Classical distribution 1Æ5 1Æ5
HLA-DR expression – 2Æ0
Maximum score 6Æ0 6Æ0
Table 7. Scores and corresponding probability of diagnosis of mycosis fungoides (MF)
Variables presenta
Patients




MF ⁄ benignb Scorec
TCR-GR not
availabled Risk of MFe
None 11 ⁄ 19 0 0Æ36 None 7 ⁄ 13 0 0Æ40 Low
D 14 ⁄ 8 1Æ5 0Æ66 D 6 ⁄ 3 1Æ5 0Æ60 Intermediate
M 8 ⁄ 2 2Æ0 0Æ75 HLA 11 ⁄ 6 2Æ0 0Æ67 Intermediate
M 6 ⁄ 2 2Æ5 0Æ73 Intermediate
GR 10 ⁄ 2 2Æ5 0Æ82 Intermediate
HLA ⁄ D 12 ⁄ 2 3Æ5 0Æ82 Intermediate
M ⁄ D 6 ⁄ 2 3Æ5 0Æ91 High
GR ⁄ D 5 ⁄ 0 4Æ0 0Æ94 M ⁄ D 5 ⁄ 0 4Æ0 0Æ86 High
GR ⁄ M 13 ⁄ 0 4Æ5 0Æ96 HLA ⁄ M 9 ⁄ 0 4Æ5 0Æ89 High
GR ⁄ M ⁄ D 7 ⁄ 0 6Æ0 0Æ99 HLA ⁄ M ⁄ D 6 ⁄ 2 6Æ0 0Æ95 High
aVariables relates to presence of classical morphology (M), distribution (D), diffuse epidermal HLA-DR expression (HLA) and T-cell receptor (TCR)
gene rearrangement (GR). bPatients relates to numbers in histologically defined benign and MF groups. cScore is derived from clinical and
laboratory evaluation from Table 6 depending on statistical model used. dPredicted probability of a diagnosis of MF based on models in Tables 2–5,
depending on TCR-GR data availability. eRisk categories of MF: low risk, P £ 0Æ40; intermediate risk, 0Æ60 £ P £ 0Æ85; high risk, P > 0Æ85.
C L I N I C A L S C O R I N G O F M F 5 1 9
 2003 British Association of Dermatologists, British Journal of Dermatology, 149, 513–522
quantified. Confirmation of strong clinical suspicion in
individual patients by histopathology is sought, but is
frequently not obtained. This need to improve diagnos-
tic ability has led to the application of adjunctive tests
to cases of suspected MF. In our study, no single
parameter yielded sufficiently discerning results to be
considered the diagnostic test. However, the combi-
nation of such tests along with the patient’s clinical
picture provides stronger evidence.
This integration of parameters to diagnose early MF
has not been explored until now. We show the relative
contribution of classic morphology and distribution to
MF diagnostics. We have shown that there is a
significant association between the presence of a TCR-
GR, classical morphology, classical distribution and
diffuse epidermal HLA-DR expression with a histolog-
ical diagnosis of MF. Logistic regression models were
developed to integrate these clinical and laboratory
data, assigning a probability (low, intermediate, high)
of having MF with a high predictive value (82% or
79%, for models using TCR-GR or HLA-DR data,
respectively).
Of all the parameters in our study, the presence of a
TCR-GR was the most discriminating criterion. Thirty-
five of 74 (47%) specimens from patients with MF
demonstrated a positive TCR-GR in contrast to two of
34 (6%) specimens from patients with benign derma-
toses (Table 1). These latter two cases were patients
with PLEVA and nonspecific spongiotic dermatitis,
respectively. Of the 57 patients with early stage MF
(stages IA, IB), 23 (40%) had a clonal TCR-GR in the
skin. Of the 17 patients with later stage disease (stages
II–IV), 12 (71%) had a clonal TCR-GR in the skin.
According to our most predictive logistic regression
model, a positive TCR-GR without other criteria resul-
ted in a 0Æ82 probability of having MF. This under-
scores the point that TCR-GR cannot serve as the one
deciding test in diagnosing MF. Although T-cell
clonality is characteristic of neoplasia, it is not conclu-
sive evidence of malignancy.32–34 For this reason, in
our models the presence of a TCR-GR alone without
classical morphology or distribution assigns only an
intermediate risk of a diagnosis of MF.
To best simulate the conditions in which our skin
scoring system would be applied, we chose to include
only those cases that could be confused with a lesion of
MF. Therefore, the odds ratios generated for each
individual diagnostic criterion may have been higher if
classical cases of benign dermatoses such as psoriasis,
atopic dermatitis or allergic contact dermatitis had
been included. However, we felt their inclusion would
not reflect the real life odds ratio given by our criteria.
Additionally, the low proportion of specimens from
patients in the MF group with a positive TCR-GR may
reflect the relative insensitivity of this technique when
carried out by Southern blot methods as compared with
the techniques utilizing polymerase chain reaction
technology, particularly in early cases of MF.22
Our logistic regression models highlight the judge-
ment of an experienced clinician by assigning the
clinical picture a high predictive value in the diagnosis
of MF. The combined presence of classical morphology
and distribution enables the diagnosis of MF to be made
with a probability of > 0Æ85 in both models (Table 7).
In the presence of a histologically consistent or
diagnostic biopsy reading, the diagnosis of MF is made.
However, in those patients with questionable or histo-
logically equivocal disease, even classical morphology
and distribution, although assigned a > 0Æ85 probab-
ility of a diagnosis of MF, may be insufficient, and
additional evaluation and application of the logistic
regression models and scoring systems may add further
evidence to help the clinician to make the correct
diagnosis.
In cases with only classical morphology or classical
distribution, adjunctive tests are particularly useful.
While morphology or distribution alone equate to a
probability of £ 0Æ75, an intermediate risk of MF in
both models, the addition of positive TCR-GR data
increases the probability to exceed the chosen threshold
of > 0Æ85 for a diagnosis of MF. Interestingly, if adding
only positive HLA-DR data, the threshold of > 0Æ85 will
Figure 5. Scores tabulated based on the two scoring systems are
correlated with the corresponding model-assigned probabilities of
diagnosis of mycosis fungoides type cutaneous T-cell lymphoma
(MF-CTCL). As scores increase, the probability of a diagnosis increases
proportionately. TCR-GR, T-cell receptor gene rearrangement.
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only be met with classical morphology, not classical
distribution, which suggests an advantage of TCR-GR
over HLA-DR data.
Once a probability and score are determined for a
given patient, treatment and follow-up decisions can
be made. Those with a high probability of having MF
(score ‡ 3Æ5 if TCR-GR data available or ‡ 4Æ0
without TCR-GR data available, P > 0Æ85) will under-
go MF-specific treatment, while those with a low
probability of disease (score ¼ 0, P £ 0Æ40) will not.
Discussions with patients and their families can
incorporate these probabilities. Patients in the inter-
mediate category require close follow-up for repeated
clinical assessment and skin biopsy as indicated, with
the decision to treat based upon the individual
situation. It should be understood that the division
between intermediate and high probability groups is
arbitrary and should be interpreted as such. For some
physicians and patients a probability > 0Æ85 for the
diagnosis of MF will be necessary, thus prompting
additional adjunctive tests until individual thresholds
are reached.
Several limitations were encountered in the develop-
ment of the current model. Statistical analysis was
complicated by missing data (Table 1). As a result, the
models were based on fewer numbers of patients (107
for the model with TCR-GR data available and 90 for
the model with HLA-DR data available). However,
results were similar when the statistical analyses were
carried out using indicator variables (data not shown).
Because patients were referred to our specialty clinic,
we realize that our population is skewed. These patients
either had MF or had features suspicious for the
disease. Given this, it is likely that utilizing a population
of patients with a more varied cross-section of benign
dermatological diseases for the benign dermatoses
group would improve the sensitivity and specificity of
our results. However, the true goal of our model is to
differentiate early cases of MF from benign disease
simulating this malignancy. Our patient groups accom-
plish this.
We have assessed the association between clinical
and laboratory data with histological diagnosis of MF
vs. benign dermatoses in our patient population, and
have integrated significant associations into logistic
regression models which assign a probability of diag-
nosis of MF. The model-derived probabilities of diagno-
sis of MF were divided into low, intermediate and high
risk, with a threshold probability for the diagnosis of
MF chosen at > 0Æ85. A simple scoring system for
patient assessment was developed to reflect these
probabilities. These models help to standardize the
diagnosis of MF as well as to provide more concrete
information to discuss with patients and their families.
This study demonstrates the high value of clinical
judgement and is the first approach to diagnosis of MF
that integrates clinical, histological and adjunctive
laboratory data. These models are likely to evolve over
time as new tests are developed.
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mycosis fungoides and Sézary’s syndrome by morphometric
analysis of lymphoid cells in the skin. Cancer 1980; 45: 2864–71.
17 Lutzner MA, Hobbs JW, Horvath P. Ultrastructure of abnormal
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